2-Fluoroethylamine → HCID 72792633, compound
Reaction equation
[CH3:1][O:2][C:3]1[N:8]=[CH:7][N:6]=[C:5]([CH2:9][N:10]2[C:18]3[C:13](=[N:14][CH:15]=[C:16]([CH3:19])[CH:17]=3)[C:12]([C:20]([OH:22])=O)=[CH:11]2)[C:4]=1[CH3:23].[F:24][CH2:25][CH2:26][NH2:27]>>[F:24][CH2:25][CH2:26][NH:27][C:20]([C:12]1[C:13]2=[N:14][CH:15]=[C:16]([CH3:19])[CH:17]=[C:18]2[N:10]([CH2:9][C:5]2[C:4]([CH3:23])=[C:3]([O:2][CH3:1])[N:8]=[CH:7][N:6]=2)[CH:11]=1)=[O:22]Participants
Procedure
See FIG. 17(d). 1-((6-methoxy-5-methylpyrimidin-4-yl)methyl)-6-methyl-1H-pyrrolo[3,2-b]pyridine-3-carboxylic acid (0.190 gm, 0.61 mmol) and 2-fluoroethanamine (0.077 g. 1.22 mmol), TEA (0.254 mL, 1.83 mmol) was added. After 3 min1-Propanephosphonic acid cyclic anhydride (0.484 g, 1.52 mmol) was added. The resulting reaction mixture was stirred at rt for 50 min. LCMS analysis confirmed the formation of required product. Reaction was diluted with DCM and water.DCM layer was extracted and washed with brine and dried over sodium sulphate and concentrated. Purification was performed on Waters RP system to get product N-(2-fluoroethyl)-1-((6-methoxy-5-methylpyrimidin-4-yl)methyl)-6-methyl-1H-pyrrolo[3,2-b]pyridine-3-carboxamide (0.090 g, 41.4%). ES+MS m/z: 358.36. 1H NMR (300 MHz, DMSO-d6) δ ppm 2.17-2.30 (3, 3 H) 2.40 (s, 3 H ) 3.59-3.73 (m, 1 H ) 3.73-3.83 (m, 1 H ) 3.94 (s, 3 H ) 4.50 (t, J=4.99 Hz, 1 H ) 4.66 (t, J=4.99 Hz, 1 H ) 5.64 (s, 2 H ) 7.76 (s, 1 H ) 8.15 (s, 1 H ) 8.35 (s, 1 H ) 8.42 (s, 1 H ) 8.87 (t, J=5.84 Hz, 1 H ).
Workup
- customThe resulting reaction mixture
Sources & evidence
- ORD record
- ord-ff2d765f96f34c368b97333ac8fe3139
- Source dataset
- uspto-grants-2015_10
- Patent number
- US09163020B2
Reaction notes
Loading…